About Immunocure
Immunocure is a Healthcare company based in Brooklyn (United States) founded in 2019 by BDL Nageswara Rao, Ravi Kumar Muttineni, and K K Raj. AI-enabled computational chemistry services for drug discovery are provided. Immunocure has raised $97.88 thousand across 1 funding round from investors including Murali Chand Ginjupalli. Its chief executive, as recorded, is BDL Nageswara Rao. Immunocure offers products and services including AxDrug Platform, Synthesis Services, Hit Identification, and Lead Optimization. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is Immunocure Inc. Its competitors include Biogen, Vir Biotechnology and ADMA Biologics; 3 of its 3 listed competitors have raised funding.
Company details
Immunocure was founded in 2019 and is based in Brooklyn, United States. Drug discovery contract research organization services are delivered, with a focus on computational chemistry enhanced by AI, machine learning, and deep learning tools. Lead compounds are developed for clients, alongside computational modeling for drug development. Additional services encompass AI-based cosmetic design and agrochemical discovery, supporting sectors like pharmaceuticals and agriculture.
- Total Equity Funding$97.88K (USD)
in 1 rounds
- Latest Funding Round$97.88K (USD), Angel Round
May 2019
Associated legal entities of Immunocure
Immunocure is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pozescaf Discovery Solutions Private Limited CIN U85320TG2019PTC135342 | Active | 11 Sep 2019 | Hyderabad, Telangana | ₹3.4 Cr | 2 | View details | |
| Carocure Discovery Solutions Private Limited CIN U73100TG2017PTC121333 | Active | 20 Dec 2017 | Hyderabad, Telangana | ₹0.0 Cr | 3 | View details |
Products & Services of Immunocure
Immunocure offers a comprehensive portfolio of products and services, including AxDrug Platform, Synthesis Services, Hit Identification, and Lead Optimization.
AI platform for virtual screening and lead generation in drug discovery
Services for optimizing and synthesizing small molecules and peptides
Process for virtual screening of databases to identify potential hits
AI-assisted optimization of lead molecules for drug candidacy
Apps and channels of Immunocure
its YouTube channel PozeSCAF Discovery Solutions has 111 subscribers and 13 videos.
Videos from Immunocure
The most watched videos on Immunocure's YouTube channel, PozeSCAF Discovery Solutions (111 subscribers). Click a video to play it here.
More on PozeSCAF Discovery Solutions.
Funding Insights of Immunocure
Immunocure has successfully raised a total of $97.88K through 1 strategic funding round. The most recent funding activity was a Angel Round of $97.88 thousand completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $97,875
- Total Rounds 1
- Last Round Angel Round — $97,875
- First Round $97,875
(May 2019)
- Investors Count 1
All 1 funding rounds of Immunocure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2019 | $97,875 | Angel Round | – | Murali Chand Ginjupalli | – |
1 investors in total: 0 institutional and 1 angel.
Investors in Immunocure
Immunocure has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Murali Chand Ginjupalli.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
MC Murali Chand Ginjupalli | unknown_f1fc6d36c7b54fd19 |
Investor details for Immunocure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Immunocure
The boards of the 2 registered companies of Immunocure currently have 5 directors; the longest-serving is Sumithra Vinod, appointed in 2017. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sumithra Vinod DIN 08013139 | Director | 20 Dec 2017 | 8 yrs 10 mo | Carocure Discovery Solutions Private Limited |
| Nadella Lakshmi Kumari DIN 08013032 | Director | 20 Dec 2017 | 8 yrs 10 mo | Carocure Discovery Solutions Private Limited |
| Ravi Kumar Muttineni DIN 07527822 | Director | 11 Sep 2019 | 7 yrs 1 mo | Pozescaf Discovery Solutions Private Limited |
| Murali Chand Ginjupalli DIN 07509263 | Director | 25 Oct 2019 | 7 yrs | Carocure Discovery Solutions Private Limited |
| Damodarlakshmi Nageswara Rao Bethamcherla DIN 03564685 | Director | 03 Jan 2020 | 6 yrs 9 mo | Pozescaf Discovery Solutions Private Limited |
People of Immunocure
3 people are tracked at Immunocure (3 in leadership).
| Name | Role | Group |
|---|---|---|
BDL Nageswara Rao | Co-Founder & CEO | Leadership |
| Co-Founder | Leadership | |
K K Raj | Co-Founder | Leadership |
Complete people profiles for Immunocure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Immunocure
Figures of Carocure Discovery Solutions Private Limited, the primary company behind Immunocure, for FY 2021. Revenue was ₹43,251 (-46% year on year). Net loss was -₹51.9 Lakh (-11990% margin). EBITDA was -₹50 Lakh (-11571% margin).
- ₹43,251Revenue · FY 2021 · -46% YoY
- -₹51.9 LakhNet loss · -11990% margin
- -₹50 LakhEBITDA · -11571% margin
- ₹78.3 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Carocure Discovery Solutions Private Limited are on its company page.
Detailed financial statements for Immunocure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Immunocure
2 dated milestones of Immunocure, from founding to its latest funding, stage changes and deals.
- Founded Immunocure is founded.
- Funding First funding round of $98K.
Competitors of Immunocure
Immunocure has 3 listed competitors in our database, 3 of them funded. They include Biogen, Vir Biotechnology and ADMA Biologics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. | |
| vir.bio | 2017 | San Francisco, United States | $216M | 417 | Developer of therapeutics for the treatment of infectious diseases | |
| admabiologics.com | 2005 | Ramsey, United States | $17.55M | 498 | Plasma-based biologics are developed for immune deficiency and infectious diseases. |
Detailed competitors of Immunocure
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Immunocure
Websites that share an audience with Immunocure (immunocure.us).
Websites whose visitors overlap most with Immunocure. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hitgen.com | 100% | 8.7K | #2,210,392 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Immunocure (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Immunocure
Immunocure was founded in 2019.
Immunocure is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
BDL Nageswara Rao is the CEO of Immunocure, as recorded in our data. They have also founded this company.
Immunocure is a funded company, having raised a total of $97.88K across 1 funding round to date. The company's 1st funding round was a Angel Round of $97.88K, raised on May 2019.
Immunocure was founded in 2019 and is based in Brooklyn, United States. Drug discovery contract research organization services are delivered, with a focus on computational chemistry enhanced by AI, machine learning, and deep learning tools. Lead compounds are developed for clients, alongside computational modeling for drug development. Additional services encompass AI-based cosmetic design and agrochemical discovery, supporting sectors like pharmaceuticals and agriculture.
Immunocure's top competitors include ADMA Biologics, Biogen and Vir Biotechnology.
Immunocure offers AxDrug Platform, Synthesis Services, Hit Identification, and Lead Optimization.
Immunocure has 1 investor. Key investors include Murali Chand Ginjupalli.
Immunocure is associated with 2 legal entities: Carocure Discovery Solutions Private Limited, Pozescaf Discovery Solutions Private Limited.
The legal entities of Immunocure currently have 5 directors, including Sumithra Vinod, Murali Chand Ginjupalli, Nadella Lakshmi Kumari and others.